Recent Graduates
Joel Vazquez, Ph.D.
Graduation Date: May 20, 2022 (supported by SPaT T32 GM106999)
Dissertation Title: Biomarkers of drug-induced liver injury: discovery, evaluation and mechanistic insights
Current Position: Regulatory Toxicologist, L’Oreal Cosmetics
Recent Publications: Click for a full list of Dr. Vazquez’s publications
Vazquez, J.H. and McGill, M.R. (2021) Redrawing the map to novel DILI biomarkers in circulation: Where are we, where should we go, and how can we get there? Livers, 1(4), 286-293. PMCID: PMC8713950
Clemens, M.M., Kennon-McGill, S., Vazquez, J.H., Stephens, O.W., Peterson, E.A., Johann, D.J., Allard, F.D., Yee, E.U., McCullough, S.S., James, L.P., Finck, B.N. and McGill, M.R. (2021) Exogenous phosphatidic acid reduce acetaminophen-induced liver injury in mice by activating hepatic interleukin-6 signaling through inter-organ crosstalk. Acta Pharm Sin B, 11(12), 3836-3846. PMCID: PMC8727922
Vazquez, J.H., Kennon-McGill, S., Byrum, S.D., Mackintosh, S.G., Jaeschke, H., Williams, D.K., Lee, W.M., Dranoff, J.A., McGill, M.R. and Acute Liver Failure Study Group (2022) Proteomics indicates lactate dehydrogenase is prognostic in acetaminophen-induced acute liver failure patients and reveals altered signaling pathways. Toxicol Sci, 187(1), 25-34. PMID: 35172013
Francesca Lobianco-Farrar, Ph.D.
Graduation Date: May 2, 2022 (supported by SPaT T32 GM106999)
Dissertation Title: Targeting redox metabolism for liver cancer treatment
Current Position: Third year medical student at UAMS completing the M.D. portion of the M.D./Ph.D. degree
Recent Publications: Click for a full list of Dr. Lobianco’s publications
Lobianco, F.V., Krager, K.J., Carter, G.S., Alam, S., Yuan, Y., Lavoie, E.G., Dranoff, J.A. and Aykin-Burns, N. (2020) The role of sirtuin 3 in radiation-induced long-term persistent liver injury. Antioxidants (Basel), 9(5), 409. PMCID: PMC7278565
Tascoiglu, A.A., Lobianco, F., Krager, K.J. and Aykin-Burns, N. (2020) Assessment of cellular oxidation using a subcellular compartment-specific redox-sensitive green fluoresecent protein. J Vis Exp, 160, 10.3791/61229. PMCID: PMC7725482
Gaba, R.C., Elkhadragy, L., Boas, F.E., Chaki, S., Chen, H.H., El-Kebir, M., Garcia, K.D., Guirini, E.F., Guzman, G., Lobianco, F.V., Neto, M.F., Newsom, J.L., Qazi, A., Regan, M., Rund, L.A., Schwind, R.M., Stewart, M.C., Thomas, F.M., Whitely, H.E., Wu, J., Schook, L.B. and Schachtschneider, K.M. (2020) Development and comprehensive characterization of porcine hepatocellular carcinoma for translational liver cancer investigation. Oncotarget, 11(28), 2686-2701. PMCID: PMC7367657
Mary “Allie” Davis Schlieff, Ph.D.
Graduation Date: July 12, 2021 (supported by SPaT T32 GM106999)
Dissertation Title: Diphenylamine NSAIDs are bioactivated into hepatotoxic quinone-species metabolites
Current Position: Postdoctoral fellow, FDA Center for Drug Evaluation and Research, St. Louis, MO
Recent Publications: Click for a full list of Dr. Scheliff’s publications
Flynn, N.R., Ward, M.D., Schleiff, M.A., Laurin, C.M.C., Farmer, R., Conway, S.J., Boysen, G., Swamidass J.S. and Miller, G.P. (2021) Bioactivation of isoxazole-containing bromodomain and extra-terminal domain (BET) inhibitors. Metabolites, 11(6), 390. PMCID: PMC8232216
Schlieff, M.A., Crosby, S., Blue, M., Schleiff, B.M., Boysen, G. and Miller, G.P. (2021) CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs, Biochem Pharmcol, 194, 114824. PMCID: PMC8710044
Cui, H., Carlson, A.S., Schleiff, M.A., Divakaran, A., Johnson, J.A., Buchholz, C.R., Zahid, H., Vail, N.R., Shi, K., Aihara, H., Miller, G.P., Topczewski, J.J., Pomerantz, W.C.K. (2021) 4-methyl-1,2,3-triazoles as N-acetyl-lysine mimics afford potent BET bromodomain inhibitors with improved selectivity. J Med Chem, 64(14), 10497-10511. PMCID: PMC8491147
Caitlin Caperton, Ph.D.
Graduation Date: May 17, 2021 (supported by SPaT Institution Match)
Dissertation Title: The dichotomous role of immune cells in thyroid cancer pathogenesis
Current Position: Fourth year medical student completing the M.D. portion of the M.D./Ph.D. degree
Recent Publications: Click for a full list of Dr. Caperton’s publications
Griffin BA, Caperton CO, Russell LN, Cabanlong CV, Wilson CD, Urquhart, KR, Martins BS, Zita MD, Patton AL, Alund AW, Owens SM, Fantegrossi WE, Moran JH, Brents, LK, In utero exposure to norbuprenorphine, a major metabolite of buprenorphine, induces fetal opioid dependence and leads to neonatal opioid withdrawal syndrome, J Pharmacol Exp Ther, 370(1): 9-17, 2019
Caperton CO, Jolly LA, Massoll N, Bauer AJ, Franco AT, Development of novel follicular thyroid cancer models with progress to poorly differentiated and anaplastic thyroid cancer, Cancers (Basel), 13(5): 1094, 2021
Julia Tobacyk, Ph.D.
Graduation Date: May 17, 2021 (supported by SPaT T32 GM106999)
Dissertation Title: Developing a novel assay for measuring OMA1 activity and investigating the role of OMA1 in renal cold storage
Current Position: Postdoctoral fellow, Department of Pharmacology and Toxicology and Scholar, Health Sciences Innovation and Entrepreneurship Postdoctoral Training Program, UAMS
Recent Publications: Click for a full list of Dr. Tobacyk’s publications
Shrum, S., Tobacyk, J., Lo, S., Parajuli, N. and MacMillan-Crow, L.A. (2020) The BK activator NS11021 partially protects rat kidneys from cold storage and transplantation-induced mitochondrial and renal injury, Arch Biochem Biophys, 688, 108410. PMCID: PMC7322695
Tobacyk, J. and MacMillan-Crow, L.A. (2021) Fluorescence-based assay for measuring OMA1 activity, Methods Mol Biol, 2276, 325-332. PMID: 34060052
Tobacyk, J., Grishma, K. and MacMillan-Crow, L.A. (2021) Overexpression of MnSOD protects against cold storage-induced mitochondrial injury but not against OMA1-dependent OPA1 proteolytic processing in rat renal proximal tubular cells, Antioxidants, 10(8), 1272. PMCID: PMC8389209
Brian Koss, Ph.D.
Graduation Date: November 18, 2020 (supported by SPaT Institution Match)
Dissertation Title: Epigenetic control of Cdkn2a.Arf protects tumor-infiltrating lymphocytes from exhaustion
Current Position: Assistant Professor, Department of Biochemistry and Molecular Biology, UAMS
Recent Publications: Click for a full list of Dr. Koss’ publications
Taylor, E.M., Koss, B., Davis, L.E. and Tackett, A.J. (2020) Histone modifications as biomarkers for immunotherapy. Methods Mol Biol, 2055, 213-228. PMID: 31502154
Trentzch, M., Nyamugenda, E., Miles, T.K., Griffin, H., Russell, S., Koss, B., Cooney, K.A., Phelan, K.D., Tackett, A.J., Iyer, S., Boysen, G. and Baldini, G. (2020) Delivery of phosphatidylethanolamine blunts stress in hepatoma cells exposed to elevated palmitate by targeting the endoplasmic reticulum. Cell Death Discov, 6, 8. PMCID: PMC7028721
Koss, B., Shields, B.D., Taylor, E.M., Storey, A.J., Byrum, S.D., Gies, A.J., Washam, C.L., Choudhury, S.R., Ahn, J.H., Uryu, H., Williams, J.B., Krager, K.J., Chiang, T-C., Mackintosh, S.G., Edmondson, R.D., Aykin-Burns, N., Gajewski, T.F., Wang, G.G. and Tackett, A.J. (2020) Epigenetic control of Cdkn2a.Arf protects tumor infiltrating lymphocytes from metabolic exhaustion. Cancer Res, 80(21), 4707-4719. PMCID: PMC642172
Brittney Garner, Ph.D.
Graduation Date: November 13, 2020 (supported by SPaT T32 GM106999)
Dissertation Title: Unrecognized participation of the lymphatic system in medication side effects and development of salt-sensitive hypertension
Current Position: Regulatory Specialist/Cook Medical
Recent Publications: Click for a full list of Dr. Garner’s publications.
Sarimollaoglu, M., Stolarz, A.J., Nedosekin, D.A., Garner, B.R., Fletcher, T.W., Galanzha, E.I., Rusch, N.J. and Zharov, V.P. (2018) High-speed microscopy for in vivo monitoring of lymph dynamics. J Biophotonics, 11(8), e201700126. PMCID: PMC6314807
Garner, B.R., Stolarz, A.J., Stuckey, D., Sarimollaoglu, M., Liu, Y., Palade, P.T., Rusch, N.J. and Mu, S. (2021) K ATP channel openers inhibit lymphatic contractions and lymph flow as a possible mechanism of peripheral edema, J Pharmcol Exp Ther, 376(1), 40-50. PMCID: PMC7745085
Van, S., Pal, S., Garner, B.R., Steed, K., Sridharan, V., Mu, S., Rusch, N.J. and Stolarz, A.J. (2021) Dantrolene prevents the lymphostasis caused by doxorubicin in the rat mesenteric circulation. Front Pharmcol, 12, 727526. PMCID: PMC8415554
Stephen Shrum, Ph.D.
Graduation Date: August 11, 2020 (supported by SPaT T32 GM106999)
Dissertation Title: The mitochondrial BK channel as a novel therapeutic target during renal cold storage and transplantation: Its role as a mitochondrial-protective factor
Current Position: Postdoctoral Fellow, Tocol Pharmaceuticals, LLC, Pharmaceutical Sciences and Scholar, Health Sciences Innovation and Entrepreneurship Postdoctoral Training Program, UAMS
Recent Publications: Click for a full list of Dr. Shrums’s publications.
Tobacyk, J., Parajuli, N., Shrum, S., Crow, J.P. and MacMillan-Crow, L.A. (2019) The first direct activity assay for the mitochondrial protease OMA1, Mitochondrian, 46, 1-5. PMCID: PMC6487223
Shrum, S., Rusch, N.J. and MacMillan-Crow, L.A. (2019) Specific BK channel activator NS11021 protects rat renal proximal tubular cells from cold-storage induced mitochondrial injury in vitro, Biomolecules, 9(12), 825. PMCID: PMC6995623
Shrum, S., Tobacyk, J., Lo, S., Parajuli, N. and MacMillan-Crow, L.A. (2020) The BK activator NS11021 partially protects rat kidneys from cold storage and transplantation-induced mitochondrial and renal injury, Arch Biochem Biophys, 688, 108410. PMCID: PMC7322695
Laura Ewing, Ph.D.
Graduation Date: July 20, 2020 (supported by SPaT T32 GM106999)
Dissertation Title: Determinants of radiation-induced gastrointestinal toxicity
Current Position: Molecular Toxicologist, Natural State Laboratories and Natural State Genomics
Recent Publications: Click for a full list of Dr. Ewing’s publications.
Ewing L.E., Miousse, I.R., Pathak, R., Skinner, C.M., Kosanke, S., Boerma, M., Hauer-Jensen, M. and Kortubash, I. (2020) NZO/HlLtJ as a novel model for the studies on the role of metabolic syndrome in acute radiation toxicity. Int J Radiat Biol, 96, 93-99. PMCID: PMC6581619
Skinner, C.M., Nookaew, I., Ewing, L.E., Wongsurawat, T., Jenjaroenpun, P., Quick, C.M., Yee, E.U., Piccolo, B.D., ElSohly, M., Walker, L.A., Gurley, B. and Kortubash, I. (2020) Potential probiotic or trigger of gut inflammation – the Janus-faced nature of cannabidiol-rich cannabis extract. J Diet Suppl, 17, 543-560. PMCID: PMC7470626
Miousse, I.R., Ewing, L.E., Skinner, C.M., Pathak, R., Garg, S., Kutanzi, K.R., Melnyk, S., Hauer-Jensen, M., and Kortubash, I. (2020) Methionine dietary supplementation potentiates ionizing radiation-induced gastrointestinal syndrome. Am J Physiol Gastrointest Liver Physiol, 318, G439-G450. PMCID: PMC7099489
Ryan MacLeod, Ph.D.
Graduation Date: August 15, 2019 (supported by SPaT Institution Match)
Dissertation Title: Novel use of CRISPR technology to investigate bone biology
Current Position: Hospital Resident, Yale School of Medicine
Recent Publications: Click for a full list of Dr. MacLeod’s publications.
Kim, H-N., Xiong, J., MacLeod, R.S., Iyer, S., Fujiwara, Y., Cawley, K.M., Han, L., He, Y., Thostenson, J.D., Ferreira, E., Jilka, R.L., Zhou, D., Almeida, M. and O’Brien, C.A. (2020) Osteocyte RANKL is required for corticol bone loss with age and is induced by senescence. JCI Insight, 5(19), e138815. PMCID: PMC7566701
Cawley, K.M., Bustamante-Gomez, N.C., Guha, A.G, MacLeod, R.S., Xiong, J., Gubrij, I., Liu, Y., Mulkey, R., Palmieri, M., Thostenson J.D., Goellner, J.J. and O’Brien, C.A. (2020) Local production of osteoprotegerin by osteoblasts suppresses bone resorption. Cell Rep, 32(10), 108052. PMCID: PMC7493998
MacLeod, R.S., Meyer, M.B., Xiong, J., Cawley, K.M., Liu, Y., Onal, M., Benkusky, N.A., Thostenson, J.D., Pike, J.W. and O’Brien, C.A. (2021) Deletion of a putative promoter-proximal Tnfsf11 regulatory region in mice does not alter bone mass or Tnfsf11 expression in vivo. PLoS One, 16(5), eo2500974. PMCID: PMC8109787
Charles Hay, Ph.D.
Graduation Date: August 14, 2019 (supported by SPaT T32 GM106999)
Dissertation Title: The development and characterization of anti-methamphetamine antibody-based gene therapies to treat methamphetamine abuse
Current Position: Postdoctoral fellow at Medical College of Wisconsin
Recent Publications: Click for a full list of Dr. Hay’s publications.
Hay, C.E., Gonzalez 3rd, G.A., Ewing, L.E., Reichard, E.E., Hambuchen, M.D., Nanaware-Kharade, N., Alam, S., Bolden, C.T., Owens, S.M., Margaritis, P. and Peterson, E.C. (2018) Development and testing of AAV-delivered single-chain variable fragments for the treatment of methamphetamine abuse. PLoS One, 13(6), e0200060. PMCID: PMC6025879
Hay, C.E., Ewing, L.E., Hambuchen, M.D., Zintner, S.M., Small, J.C., Bolden, C.T., Fantegrossi, W.E., Margaritis, P., Owens, S.M. and Peterson, E.C. (2020) The development and characterization of an scFv-Fc fusion-based gene therapy to reduce the psychostimulant effects of methamphetamine abuse. J Pharmcol Exp Ther, 374(1), 16-23. PMCID: PMC7289050
Samantha McClenahan, Ph.D.
Graduation Date: June 19, 2019 (supported by SPaT T32 GM106999)
Dissertation Title: Development and testing of a vaccine for 3,4-methylenedioxypyrovalerone (MDPV) and α-pyrrolidinovalerophenone (α-PVP)
Current Position: Postdoctoral fellow at Vanderbilt University
Recent Publications: Click for a full list of Dr. McClenahan’s publications.
McClenahan, S.J., Kormos, C.M., Gunnell, M, Hambuchen, M.D., Lamb, P., Carroll, F.I., Lewin, A.H., Peterson, E.C. and Owens, S.M. (2020) Design, synthesis and biological evaluation of bi-specifc vaccine against α-pyrrolidinovalerophenone (α-PVP) and 3,4-methylenedioxypyrovalerone (MDPV) in rats. Vaccine, 38(2), 336-344. PMCID: PMC6938543
McClenahan, S.J., Gunnell, M.G., Owens, S.M. and Fantegrossi, W.E. (2020) Active vaccination reduces reinforcing effects of MDPV in male Sprague-Dawley rats trained to self-administer cocaine. Psychopharmacology (Berl), 237(9), 2613-2620. PMCID: PMC7502518
McClenahan, S.J., Gunnell, M. and Owens, S.M. (2021) Pharmacokinetics of α-pyrrolidinovalerophenone in male rats with and without vaccination with an α-pyrrolidinovalerophenone vaccine. J Pharm Pharm Sci, 24, 267-276. PMCID: PMC8604100
Bill Hyatt, M.D., Ph.D.
Graduation Date: May 28, 2019 (supported by SPaT institution match)
Dissertation Title: Acute and persistent impulsive effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV)
Current Position: Resident, Psychiatry, UAMS Psychiatric Research Institute
Recent Publications: Click for a full list of Dr. Hyatt’s publications.
Berquist, M.D., Hyatt, W.S., Bauer-Erickson, J., Gannon, B.M., Norwood, A.P. and Fantegrossi, W.E. (2018) Phencyclidine-like in vivo effects of methoxetamine in mice and rats, Neuropharmacology, 134(Pt A), 158-166. PMCID: PMC5818319
Hyatt, W.S., Berquist, M.D., Chitre, N.M., Russell, L.N., Rice, K.C., Murnane, K.S. and Fantegrossi, W.E. (2019) Repeated administration of synthetic cathinone 3,4-methylenedioxypyrovalerone persistently increases impulsive choice in rats, Behav Pharmacol, 30(7), 555-565. PMID: 31211703
Hyatt, W.S., Hirsh, C.E., Russell, L.N., Chitre, N.M., Murnane, K.S., Rice, K.C. and Fantegrossi, W.E. (2020) The synthetic cathinone 3,4-methylenedioxypyrovalerone increases impulsive action in rats, Behav Pharmcol, 31(4), 309-321. PMID: 32101987
Daniel Meeker, Ph.D.
Graduation Date: February 15, 2018 (supported by SPaT institution match)
Dissertation Title: Development of a targeted nanotherapeutic approach to the treatment of biofilm-associated Staphylococcus aureus infection
Current Position: Resident in Orthopaedic surgery, University of Iowa
Recent Publications: Click for a full list of Dr. Meeker’s publications.
Meeker, D.G., Chen, J. and MS. (2016) Could targeted, antibiotic-loaded gold nanoconstructs be a new magic bullet to fight infection? Nanomedicine (Lond), 11, 2379-2382. PMCID: PMC27529572
Meeker, D.G., Wang, T., Harrington, W.N., Zharov, V.P., Johnson, S.A., Jenkins, S.V., Oyibo, S.E., Walker, C.M., Mills, W.B., Shirtliff, M.E., Beenken, K.E., Chen, J., Smeltzer, M.S. (2018) Versatility of targeted antibiotic-loaded gold nanoconstructs for the treatment of biofilm-associated bacterial infections. Int J Hyperthermia, 34(2), 209-2019. PMCID: PMC6095133
Beenken, K.E., Campbell, M.J., Ramirez, A.M., Alghazali, K., Walker, C.M., Jackson, B., Griffin, C., King, W., Bourdo, S.E. Rifkin, R., Hecht, S., Meeker, D.G., Anderson, D.E., Biris, A.S. and Smeltzer, M.S. (2021) Evaluation of a bone filler scaffold for local antibiotic delivery to prevent Staphylococcus aureus infection in a contaminated bone defect. Sci Rep, 11(1), 10254. PMCID: PMC8119729
Alex W. Alund, Ph.D.
Graduation Date: June 10, 2016 (supported by SPaT T32 GM106999)
Dissertation Title: The role of reactive oxygen species in alcohol-induced osteopenia and the regulation of bone turnover
Current Position: Postdoctoral fellow, Pfizer (Connecticut)
Recent Publications: Click for a full list of Dr. Alund’s publications.
Watt, J., Alund, A.W., Pulliam, C.F., Mercer, K.E., Suva, L.J., Chen, J-R. and Ronis, M.J.J. (2018) NOX4 deletion in male mice exacerbates the effect of ethanol on trabecular bone and osteoblastogenesis. J Pharmcol Exp Ther, 366(1), 46-57. PMCID: PMC5988025
Chen, J-R, Lazarenko, O.P., Zhao, H., Alund, A.W., Shankar, K. (2018) Maternal obesity impairs skeletal development in adult offspring. J Endocrinol, 239(1), 33-47. PMCID: PMC6145139
Ronis, M.J., Watt, J., Pulliam, C.F., Williams, A.E., Alund, A.W., Haque, E., Gadupudi, G.S., and Robertson, L.W. (2020) Skeletal toxicity resulting from exposure of growing male rats to coplanar PCB 126 is associated with disruption of calcium homeostasis and the GH-IGF-1 axis and direct effects on bone formation. Arch Toxicol, 94(2), 389-399. PMCID: PMC7047627
Clark R. Sims, Ph.D.
Graduation Date: November 4, 2016 (supported by SPaT T32 GM106999)
Dissertation Title: Preclinical studies of targeted therapy in an infant model of sepsis-induced cardiorenal syndrome
Current Position: Assistant Staff Scientist, Arkansas Children’s Nutrition Center
Recent Publications: Click for a full list of Dr. Sims’ publications.
Wang, Z., Sims, C.R., Patil, N.K., Gokden, N. and Mayeux, P.R.,(2015) Pharmacological targeting of sphingosine-1-phosphate receptor 1 improves the renal microcirculation during sepsis in the mouse. J Pharmacol Exp Ther, 352, 61-66. PMCID: PMC4279105
Sims, C.R., Nguyen, T.C. and Mayeux, P.R. (2016) Could biomarkers direct therapy for the septic patient? J Pharmacol Exp Ther, 357, 228-239. PMCID: PMC4851319
Sims, C.R., Singh, S.P., Mu, S.., Gokden, N., Zakaria, D., Nguyen, T.C. and Mayeux, P.R., (2017) Rolipam improves outcome in a rat model of infant sepsis-induced cardiorenal syndrome, Front Pharmcol, 8, 237. PMCID: PMC5413568
Emily R Holthoff, Ph.D.
Graduation Date: May 2, 2016 (supported by SPaT institution match)
Dissertation Title: Identifying Pathologic and Molecular Features that Predict Adverse Clinical Outcomes in Vulvar Squamous Cell Carcinoma
Current Position: Resident Physician, Pediatrics, University of Arkansas for Medical Sciences
Recent Publications: Click for a full list of Dr. Holthoff’s publications.
Holthoff, E., Spencer, H., Kelly, T., Post, S.R. and Quick, C.M. (2016) Pathologic features of aggressive vulvar squamous cell carcinoma are associated with an epithelial-mesenchymal transition. Hum Pathol. 56, 22-30. PMCID: PMC5021565
Holthoff, E.R., Byrum, S.D., Mackintosh, S.G., Kelly, T., Tackett, A.J., Quick, C.M and Post, S.R. (2017) Vulvar squamous cell carcinoma aggressiveness in associated with differential expression of collagen and STAT1. Clin Proteomics, 14, 40. PMCID: PMC5717999
Post, G.R., Yuan, Y., Holthoff, E.R., Quick, C.M. and Post, S.R. (2019) Identification of a novel monocytic phenotype in classic Hodgkin Lymphoma tumor microenvironment. PLoS One, 14(11), e0224621. PMCID: PMC6850552
Predoctoral Fellowships Awarded to Trainees
- Brian Koss – NRSA NIH F31 CA232464 “Epigenetic regulation of metabolic stress pathways in melanoma infiltrating lymphocytes” (2019-2022)
- Laura Ewing – PhRMA Foundation Predoctoral Fellowship “Role of methionine-gut microbiome interaction in radiation-induced gastrointestinal toxicity” (2019-2020)
- Samantha McClenahan – NRSA NIH F31 DA046121 “Development of an enantiomeric specific vaccine for 3,4-methylenedioxypyrovalerone (MDPV) abuse” (2018-2021)
- Julia Tobacyk – PhRMA Foundation Predoctoral Fellowship “The therapeutic role of OMA1 in cold storage induced nephrotoxicity” (2018-2020)
- Stephen Shrum – American Heart Association Predoctoral 16PRE30830010 “Role of mitoBK channels in rat renal cold preservation” (2016-2018)
- Lascelles Lyn-Cook, Jr. – Southern Regional Education Board Doctoral Scholars (2016-2017)
- Clark Sims – NRSA NIH F31 DK104533 “Targeting renal perfusion and mitochondrial oxidants in a model of infant sepsis” (2015-2016)
- Clark Sims – American Heart Association Predoctoral 15PRE20450050 “Renal microcirculatory failure in a rat pup model of pediatric sepsis” (2014)
- Daniel Meeker – NRSA NIH F31 (recommended for funding, 2017)
Time to degree for SPaT trainees (Ph.D. only)
4.14 years